Virkninger af glukagonlignende peptider på galdeblæremotiliteten

Translated title of the contribution: Effects of glucagon-like peptides on gallbladder motility

Ida M Gether, Christina Nexøe-Larsen, David P Sonne, Filip K Knop


As cases of gallbladder-related adverse events have been reported in patients treated with glucagon-like peptide (GLP)-1 receptor agonists and GLP-2 receptor agonists, studies have investigated the effects of these hormones on the enterohepatic circulation of bile acids and gallbladder motility. Results suggest, that bile acids and GLP-2 counteract postprandial cholecystokinin-mediated gallbladder contraction, while GLP-1 may delay gallbladder refilling. This provides important information on the effect and safety of drugs based on GLP-1 and GLP-2, respectively.

Translated title of the contributionEffects of glucagon-like peptides on gallbladder motility
Original languageDanish
JournalUgeskrift for Laeger
Issue number50
Publication statusPublished - 10 Dec 2018


Dive into the research topics of 'Effects of glucagon-like peptides on gallbladder motility'. Together they form a unique fingerprint.

Cite this